Blood and Cystic Fluid From Patients Undergoing Surgery for Worrisome Pancreatic Cysts

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTranslational Genomics Research Institute

About this trial

The goal of this study is to collect biospecimens (blood and cystic fluid) and data from participants who have a pancreatic cyst that requires surgical resection. The blood and fluid samples will be analyzed for research into DNA, RNA, and proteins.

Eligibility criteria

Qualifiers

Voluntarily agree to participate by giving written informed consent prior to any study-specific procedures.

Subject at least 18 years of age and able to provide consent. Subject is willing and able to comply with requirements of the protocol.

Radiologically documented cyst of the pancreas for which surgical removal is clinically indicated.

Patient will be undergoing a surgical resection of their pancreatic cystic neoplasm.

Disqualifiers

Patient who is pregnant at the time of study enrollment and sample collection.

Patient will not be undergoing clinically indicated surgery for a pancreatic cystic neoplasm.

Patient is unwilling or unable to provide informed consent or comply with study procedures.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

30 Participants
are grouped into 1 trial group

Sponsors and collaborators

Translational Genomics Research Institute

Lead sponsor

Hoag Memorial Hospital Presbyterian

Collaborator

City of Hope National Medical Center

Collaborator

Piedmont Healthcare

Collaborator